The Association between Neutrophil‐to‐Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
Background. Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
[PDF][PDF] The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
T Adane, M Melku, YB Worku, A Fasil, M Aynalem… - 2023 - researchgate.net
Background. Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
T Adane, M Melku, YB Worku, A Fasil… - Journal of Diabetes …, 2023 - search.proquest.com
Background. Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
T Adane, M Melku, YB Worku, A Fasil… - Journal of diabetes …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
[PDF][PDF] The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
T Adane, M Melku, YB Worku, A Fasil, M Aynalem… - 2023 - scienceopen.com
Background. Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
[HTML][HTML] The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
T Adane, M Melku, YB Worku, A Fasil… - Journal of Diabetes …, 2023 - ncbi.nlm.nih.gov
Background Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
T Adane, M Melku, YB Worku, A Fasil… - Journal of Diabetes …, 2023 - search.ebscohost.com
Abstract Background. Glycated hemoglobin (HbA1c) is a commonly used clinical marker to
monitor the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to …
monitor the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to …
The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
T Adane, M Melku, YB Worku, A Fasil… - Journal of Diabetes …, 2023 - europepmc.org
Background Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
[引用][C] The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
T Adane, M Melku, YB Worku, A Fasil, M Aynalem… - 2023 - europepmc.org
Background. Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …